Causes of death

Kintara Therapeutics to Present at the BTIG Virtual Biotechnology Conference on August 9, 2021

Retrieved on: 
Wednesday, August 4, 2021
Cancer, Branches of biology, Causes of death, GBM, Glioblastoma, Glioblast, Breast cancer

Mr. Zarrabian will deliver his corporate presentation on Monday, August 9, 2021 at 2:00 p.m.

Key Points: 
  • Mr. Zarrabian will deliver his corporate presentation on Monday, August 9, 2021 at 2:00 p.m.
  • The live webcast will be available on the BTIG conference website at the time of the event, after which it will be available through BTIG research access.
  • Investors can also request a one-on-one meeting with Mr. Zarrabian to be arranged following the conclusion of the conference.Please contact a BTIG conference representative.
  • Kintara is currently developing two Phase 3-ready therapeutics, VAL-083 for glioblastoma multiforme (GBM) and REM-001 for cutaneous metastatic breast cancer (CMBC).

People living with lung cancer launch a social media takeover!

Retrieved on: 
Wednesday, July 28, 2021
Cancer, Health, Causes of death, Prostate cancer, Breast cancer, War on Cancer, Norris Cotton Cancer Center

Los Angeles, CA, July 28, 2021 (GLOBE NEWSWIRE) -- Join dozens of patient advocates living with lung cancer and meet the researchers working to find better treatments for the disease during a live, 4-hour social media takeover on Facebook, Twitter and Instagram on World Lung Cancer Day, August 1st.

Key Points: 
  • Los Angeles, CA, July 28, 2021 (GLOBE NEWSWIRE) -- Join dozens of patient advocates living with lung cancer and meet the researchers working to find better treatments for the disease during a live, 4-hour social media takeover on Facebook, Twitter and Instagram on World Lung Cancer Day, August 1st.
  • However, lung cancer research is still one of the least funded cancers given that lung cancer kills more people than breast, colon and prostate cancer COMBINED.
  • The World Lung Cancer Day social media takeover is bringing patient advocates and researchers together to advocate and raise funds for increased research funding that helps people living with lung cancer do what they love to do every day.
  • LCFAs mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.

Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors

Retrieved on: 
Monday, July 26, 2021
Cancer, Cancer research, American Association for Cancer Research, Causes of death, Oncology, Health, Clinical medicine

HOUSTON and SINGAPORE, July 26, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that internationally renowned scientist and medical oncologist, Dr. Thomas J Lynch, Jr, MD, has been appointed to its Board as a Non-Executive Director, effective immediately.

Key Points: 
  • HOUSTON and SINGAPORE, July 26, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that internationally renowned scientist and medical oncologist, Dr. Thomas J Lynch, Jr, MD, has been appointed to its Board as a Non-Executive Director, effective immediately.
  • His work has received awards from both the American Association for Cancer Research and the International Association for the Study of Lung Cancer.
  • "I look forward to joining Hummingbird's Board of Directors and working with the leadership team and members of the board on the company's strategic growth and development plans," said Dr.
  • "We need more options for cancer patients who don't respond to current treatments, and Hummingbird has many interesting programs in development."

"Promising development in the fight with cancer using artificial intelligence" with a new privacy-preserving approach named MEDomics

Retrieved on: 
Thursday, July 22, 2021
Oncology, Cancer, Causes of death, Health, Prostate cancer, Anil Potti

SAN FRANCISCO, July 22, 2021 /PRNewswire/ -- Published first in Nature Cancer, "MEDomics" refers to a novel approach using hospital based medical notes to refine predictions and prognosis in cancer patients over time.

Key Points: 
  • SAN FRANCISCO, July 22, 2021 /PRNewswire/ -- Published first in Nature Cancer, "MEDomics" refers to a novel approach using hospital based medical notes to refine predictions and prognosis in cancer patients over time.
  • Co-senior author and Chair of the department of Radiation Oncology at UCSF added: "With this data we were able to validate findings of published clinical trials using real world data, e.g.
  • the positive impact of immunotherapy in lung cancer.
  • In addition, there are exciting opportunities to generate hypothesis based on associations from patients' individual health profiles, and risk factors."

PharmaCyte Biotech Provides Update to Nasdaq Listing Efforts and Presents Scientific Publications Supporting Pancreatic Cancer Treatment

Retrieved on: 
Thursday, July 22, 2021
Research, Medical devices, FDA, Clinical trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, Gastrointestinal cancer, Pancreatic cancer, Cancer, Clinical medicine, Medical specialties, Causes of death

Our hope is that PharmaCyte will be trading on the highly respected platform and will become a Nasdaq listed company as early as next week.

Key Points: 
  • Our hope is that PharmaCyte will be trading on the highly respected platform and will become a Nasdaq listed company as early as next week.
  • Waggoner continued, With a number of recent well-respected scientific review publications supporting the approach that our technology uses as a promising treatment for pancreatic cancer, it is a validation, of sorts, of our approach and technology against the disease by independent scientists.
  • Three recently published high profile international medical and scientific review articles have highlighted PharmaCytes pancreatic cancer treatment.
  • The articles mention (i) the treatments use in clinical trials to develop a cellular microencapsulation technology to treat pancreatic cancer; (ii) the use of prodrugs in its treatment; and (iii) the treatments role in improving the pancreatic cancer treatment landscape.

Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day

Retrieved on: 
Wednesday, July 21, 2021
Brain tumor, Health, Causes of death, Cancer, Glioblastoma, Oncology, Clinical medicine, GBM

SYDNEY, July 21, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a leading drug development company in the field of brain cancer, today recognizes Glioblastoma (GBM) Awareness Day and calls for a greater focus on research from industry, academia, and government in order to better treat the disease.

Key Points: 
  • SYDNEY, July 21, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a leading drug development company in the field of brain cancer, today recognizes Glioblastoma (GBM) Awareness Day and calls for a greater focus on research from industry, academia, and government in order to better treat the disease.
  • GBM is the most common and most aggressive form of primary brain cancer, and it is expected that approximately 13,000 Americans will receive a GBM diagnosis in 2021.
  • The GBM AGILE clinical trial, sponsored by the Global Coalition for Adaptive Research, a 501(c)(3) non-profit organization, commenced recruitment in June 2019.
  • For further information on GBM Awareness Day please visit: https://braintumor.org/take-action/act-on-gbm-day/
    Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA) is an oncology-focused drug development company, based in Sydney, Australia.

Legendary New York City Free Cancer Support Organization Is Now Red Door Community℠

Retrieved on: 
Thursday, July 15, 2021
Cancer, Causes of death

Red Door Community remains New York City's preeminent nonprofit cancer support organization, helping everyone and anyone impacted by cancer.

Key Points: 
  • Red Door Community remains New York City's preeminent nonprofit cancer support organization, helping everyone and anyone impacted by cancer.
  • Red Door Community is committed to providing unwavering support at every stage of the cancer experience, so no one faces cancer alone.
  • The demand for their free cancer support program increased dramatically during the pandemic and participation in the Red Door Community program grew by 55%, an unprecedented increase in one year.
  • As a bi-lingual organization, Red Door Community was able to increase their support to the Latino cancer community, virtually.

2021 Insights on the Head & Neck Cancers Global Market - Epidemiology Forecasts to 2035 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 9, 2021
Pharmaceutical, Health, Oncology, Otorhinolaryngology, Health effects of tobacco, Head and neck cancer, Cancer, Health, Causes of death, Carcinogens, Infectious causes of cancer, Head and Neck Cancer Alliance, HPV-positive oropharyngeal cancer

The "Global Head & Neck Cancers Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Head & Neck Cancers Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.
  • The research report provides Head & Neck Cancers epidemiology, demographics, and patient flow.
  • The research provides population data to characterize Head & Neck Cancers patients, history of the disease at the population level (Head & Neck Cancers prevalence, Head & Neck Cancers incidence) and at the clinical level (from diagnosis to treated patients).
  • Head & Neck Cancers patient flow: Head & Neck Cancers prevalence, diagnosed, and drug-treated patients
    Demographics: Head & Neck Cancers patients by age group, gender
    The data from this research will help executives:
    Establish basis for Head & Neck Cancers market sizing, assessing market potential, and developing drug forecast models
    Identify Head & Neck Cancers patients segments through age groups, gender, and disease sub-types
    Evaluate Head & Neck Cancers market opportunities, identify target patient population
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210709005291/en/

Cherry Creek Mortgage Holds Seventh Annual Fundraising Effort Supporting the Pancreatic Cancer Action Network

Retrieved on: 
Wednesday, July 7, 2021
Pancreatic Cancer Action Network, Pancreatic Cancer Action, Pancreatic cancer, Cancer, Cherry Creek, Causes of death, Medical specialties, United States

DENVER, July 7, 2021 /PRNewswire/ -- Cherry Creek Mortgage is celebrating its ongoing partnership with the Pancreatic Cancer Action Network (PanCAN) and recently hosted its seventh annual Swing for a Cure golf tournament to raise funds for the non-profit organization.

Key Points: 
  • DENVER, July 7, 2021 /PRNewswire/ -- Cherry Creek Mortgage is celebrating its ongoing partnership with the Pancreatic Cancer Action Network (PanCAN) and recently hosted its seventh annual Swing for a Cure golf tournament to raise funds for the non-profit organization.
  • "Our Cherry Creek Mortgage community has been directly affected by pancreatic cancer, and we are proud to honor the legacy of those we have lost by supporting PanCAN's life-saving mission."
  • "PanCAN is so fortunate to have Cherry Creek Mortgage as a long-time partner in the fight against pancreatic cancer.
  • The Pancreatic Cancer Action Network (PanCAN) leads the way in accelerating critical progress for pancreatic cancer patients.

2021 ESPYS and Sports Humanitarian Awards to Benefit the V Foundation’s Stuart Scott Fund

Retrieved on: 
Tuesday, July 6, 2021
Research, Entertainment, Sports, Events, Concerts, Philanthropy, Oncology, Other Sports, Fund Raising, Foundation, TV and Radio, Science, Health, Stuart Scott, Cancer research, Cancer, Mass media in the United States, Causes of death

The V Foundation for Cancer Research, a top-rated cancer research charity, and ESPN announce the 2021 ESPYS presented by Capital One will benefit cancer research funded through the V Foundation.

Key Points: 
  • The V Foundation for Cancer Research, a top-rated cancer research charity, and ESPN announce the 2021 ESPYS presented by Capital One will benefit cancer research funded through the V Foundation.
  • In addition, the V Foundations Stuart Scott Memorial Cancer Research Fund has been selected as the beneficiary of the seventh annual Sports Humanitarian Awards .
  • We remain committed to our long-standing tradition of raising funds for cancer research, especially for those who are disproportionately affected through the Stuart Scott Fund.
  • #ScoopsForStu will raise awareness and promote funding for the Stuart Scott Memorial Cancer Research Fund while celebrating Stuarts favorite treat.